Natural history of liver disease in a large international cohort of children with Alagille syndrome: Results from the GALA study. Abstract Background and Aims Alagille syndrome (ALGS) is a multisystem disorder, characterized by cholestasis. Existing outcome data are largely derived from tertiary centers, and real‐world data are lacking.
Shannon M. Vandriel +93 more
wiley +1 more source
Serum bile acids as a prognostic biomarker in biliary atresia following Kasai portoenterostomy
Serum bile acid levels predict outcomes in patients with biliary atresia who achieve normalized bilirubin levels after Kasai portoenterostomy. Abstract Background and Aims In biliary atresia, serum bilirubin is commonly used to predict outcomes after Kasai portoenterostomy (KP).
Sanjiv Harpavat +22 more
wiley +1 more source
BackgroundThis study aimed to evaluate the efficacy and adverse events of esophageal variceal ligation (EVL) vs. EVL combined with endoscopic injection sclerosis (EIS) in the therapy of esophageal varices.MethodsPatients from January 2017 to August 2021 ...
Xiaofen Yue +12 more
doaj +1 more source
Appropriateness of Indications and Factors Associated With Abnormal Findings in Upper Gastrointestinal Endoscopy at the National Referral Hospital, Bhutan: A Cross-Sectional Study. [PDF]
ABSTRACT Introduction Upper gastrointestinal endoscopy (UGIE) is a commonly performed procedure for evaluating complaints related to the upper gastrointestinal tract. It serves both diagnostic and therapeutic purposes. Over the last decade, there has been an increasing demand for UGIE, and selecting patients for the procedure according to standard ...
Gawa T, Dorjey Y, Dargay S.
europepmc +2 more sources
Endoscopic management of esophageal and gastric lesions with underlying varices
Recent developments in endoscopic techniques have contributed to establishing endoscopy as an essential tool in the management of different types of esophageal and gastric lesions. However, management of these lesions with underlying varices is challenging, considering the technical difficulties and increased risk of bleeding it entails with current ...
Dias, Emanuel +2 more
openaire +2 more sources
Background Cyanoacrylate alone or in combination with other interventions, can be used to achieve variable rates of success in preventing rebleeding. Our study aims to assess the pooled risk of gastric and esophageal varices rebleeding after an initial ...
Zixuan Hu +4 more
doaj +1 more source
Comparison of transjugular intrahepatic portosystemic shunt with covered stent and balloon-occluded retrograde transvenous obliteration in managing isolated gastric varices [PDF]
OBJECTIVE: Although a transjugular intrahepatic portosystemic shunt (TIPS) is commonly placed to manage isolated gastric varices, balloon-occluded retrograde transvenous obliteration (BRTO) has also been used. We compare the long-term outcomes from these
Kim, Seung Kwon +3 more
core +3 more sources
Coil-Assisted Retrograde Transvenous Obliteration (CARTO) for the Treatment of Portal Hypertensive Variceal Bleeding: Preliminary Results. [PDF]
ObjectivesTo describe the technical feasibility, safety, and clinical outcomes of coil-assisted retrograde transvenous obliteration (CARTO) in treating portal hypertensive non-esophageal variceal hemorrhage.MethodsFrom October 2012 to December 2013, 20 ...
Busuttil, Ronald +11 more
core +2 more sources
Upper gastrointestinal bleeding is differentiated based on clinical needs into variceal and non-variceal bleeding. The cause of varices bleeding is portal hypertension, both cirrhosis and non-cirrhosis. Gastric varices occur less than esophageal varices,
Jualita Heidy Saputri, Budi Widodo
doaj +1 more source
Endoscopic Innovation Treatment Strategy in Hepatocellular Carcinoma (HCC) Patients Before Immunotherapy: A Case Series Study in Unselected Patients. [PDF]
ABSTRACT Hepatocellular carcinoma remains a major problem in Asia as well as globally. Most patients present at the late stage of the disease. Currently, several types of immunotherapy (IT) have been studied for its efficacy in treating hepatocellular carcinoma, such as atezolizumab and bevacizumab, which work as inhibitors in checkpoints and ...
Syofyan SD +8 more
europepmc +2 more sources

